PANEBIANCO, MARTINA
PANEBIANCO, MARTINA
A Case of Pathological Complete Response and Resolution of Dermatomyositis Following Neoadjuvant Chemotherapy in HER2-Positive Early Breast Cancer
2021 Piras, Marta; Panebianco, Martina; Garibaldi, Matteo; Roberto, Michela; Merlonghi, Gioia; Pellegrini, Patrizia; Marchetti, Paolo
Comparison of 18F FDG PET-CT AND CECT in pretreatment staging of adults with Hodgkin's lymphoma
2019 Panebianco, Martina; Bagni, Oreste; Cenfra, Natalia; Mecarocci, Sergio; Ortu La Barbera, Elettra; Filippi, Luca; Codacci-Pisanelli, Giovanni; Biondi, Tommaso; Laghi, Andrea; Cimino, Giuseppe
Drug–drug interactions and pharmacogenomic evaluation in colorectal cancer patients. The new drug-pin® system comprehensive approach
2021 Roberto, M.; Rossi, A.; Panebianco, M.; Pomes, L. M.; Arrivi, G.; Ierino, D.; Simmaco, M.; Marchetti, P.; Mazzuca, F.
Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach
2022 Schipilliti, Fm; Onorato, M; Arrivi, G; Panebianco, M; Lerinò, D; Milano, A; Roberto, M; Capalbo, C; Mazzuca, F
Metastatic renal cell carcinoma management: from molecular mechanism to clinical practice
2021 Roberto, M.; Botticelli, A.; Panebianco, M.; Aschelter, A. M.; Gelibter, A.; Ciccarese, C.; Minelli, M.; Nuti, M.; Santini, D.; Laghi, A.; Tomao, S.; Marchetti, P.
The evolving impact of genomic biomarker landscape in stage II colorectal cancer (CRC).
2020 Arrivi, G.; Marchetti, P.; Pilozzi, E.; Montori, A.; Balducci, G.; Mercantini, P.; Laghi, A.; Ierinò, D.; Panebianco, M.; Mazzuca, F.; Roberto, M.
The potential role of genomic signature in stage II relapsed colorectal cancer (CRC) patients: a mono-institutional study
2022 Roberto, M.; Arrivi, G.; Pilozzi, E.; Montori, A.; Balducci, G.; Mercantini, P.; Laghi, A.; Ierino, D.; Panebianco, M.; Marinelli, D.; Tomao, S.; Marchetti, P.; Mazzuca, F.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A Case of Pathological Complete Response and Resolution of Dermatomyositis Following Neoadjuvant Chemotherapy in HER2-Positive Early Breast Cancer | 2021 | Piras, Marta; Panebianco, Martina; Garibaldi, Matteo; Roberto, Michela; Merlonghi, Gioia; Pellegrini, Patrizia; Marchetti, Paolo | |
Comparison of 18F FDG PET-CT AND CECT in pretreatment staging of adults with Hodgkin's lymphoma | 2019 | Panebianco, Martina; Bagni, Oreste; Cenfra, Natalia; Mecarocci, Sergio; Ortu La Barbera, Elettra; Filippi, Luca; Codacci-Pisanelli, Giovanni; Biondi, Tommaso; Laghi, Andrea; Cimino, Giuseppe | |
Drug–drug interactions and pharmacogenomic evaluation in colorectal cancer patients. The new drug-pin® system comprehensive approach | 2021 | Roberto, M.; Rossi, A.; Panebianco, M.; Pomes, L. M.; Arrivi, G.; Ierino, D.; Simmaco, M.; Marchetti, P.; Mazzuca, F. | |
Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach | 2022 | Schipilliti, Fm; Onorato, M; Arrivi, G; Panebianco, M; Lerinò, D; Milano, A; Roberto, M; Capalbo, C; Mazzuca, F | |
Metastatic renal cell carcinoma management: from molecular mechanism to clinical practice | 2021 | Roberto, M.; Botticelli, A.; Panebianco, M.; Aschelter, A. M.; Gelibter, A.; Ciccarese, C.; Minelli, M.; Nuti, M.; Santini, D.; Laghi, A.; Tomao, S.; Marchetti, P. | |
The evolving impact of genomic biomarker landscape in stage II colorectal cancer (CRC). | 2020 | Arrivi, G.; Marchetti, P.; Pilozzi, E.; Montori, A.; Balducci, G.; Mercantini, P.; Laghi, A.; Ierinò, D.; Panebianco, M.; Mazzuca, F.; Roberto, M. | |
The potential role of genomic signature in stage II relapsed colorectal cancer (CRC) patients: a mono-institutional study | 2022 | Roberto, M.; Arrivi, G.; Pilozzi, E.; Montori, A.; Balducci, G.; Mercantini, P.; Laghi, A.; Ierino, D.; Panebianco, M.; Marinelli, D.; Tomao, S.; Marchetti, P.; Mazzuca, F. |